Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a digital assistant help clinics catch dengue fever faster?

NCT ID NCT04582474

Diagnosis Sponsor: Foundation for Innovative New Diagnostics, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Dengue fever is common in Burkina Faso, but primary health clinics often rely only on malaria rapid tests when a child arrives with fever. Researchers are testing a digital module that walks health workers through the country's dengue management guideline and pairs it with dengue rapid diagnostic tests. The study enrolls people older than 6 months who come to a clinic with fever and no clear other cause. It measures how often the module is used, whether staff follow its steps, and how well case reports reach the surveillance system.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a digital dengue decision-support module paired with dengue rapid diagnostic tests
What this could lead to
If it works, health workers in Burkina Faso could identify and manage dengue fever more reliably, and cases could reach the surveillance system faster.
What could go wrong
The study tests usability and reporting performance, not whether patients get better. A digital tool can fail if staff skip steps, if rapid tests misread, or if the module does not fit busy clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

335 people

The number who actually took part.

Started

Sep 2020

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older than 6 month * Presentation with fever (axillary temperature ≥ 37,5⁰C) or history of fever for 2-7 days without localizing signs of another pathology such as malaria diagnosed by RDT * Malaria diagnosis: negative malaria RDT performed at the the study site by a nurse as part of the routine consultation, or a positive malaria RDT with antimalarial treatment failure Exclusion Criteria: * Neonates (0-2 months) and children ≤ 6 month for operational reasons such as difficulties with blood draw * Patients with severe disease requiring urgent care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dengue are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dengue disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dengue

Contacts and locations

Locations

  • Centre de Santé et de Promotion Sociale (Sandogo)

    Ouagadougou, District Boulmiougou, Burkina Faso

  • Centre de Santé et de Promotion Sociale (Secteur 16)

    Ouagadougou, District Boulmiougou, Burkina Faso

More trials for these conditions

Other studies related to the condition(s) this trial covers.